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Protein secretion plays a crucial role for bacterial pathogens, exemplified by facultative
human-pathogen Vibrio cholerae, which secretes various proteinaceous effectors at
different stages of its lifecycle. Accordingly, the identification of factors impacting on
protein secretion is important to understand the bacterial pathophysiology. PglLVc , a
predicted oligosaccharyltransferase of V. cholerae, has been recently shown to exhibit
O-glycosylation activity with relaxed glycan specificity in an engineered Escherichia
coli system. By engineering V. cholerae strains to express a defined, undecaprenyl
diphosphate-linked glycoform precursor, we confirmed functional O-linked protein
glycosylation activity of PglLVc in V. cholerae. We demonstrate that PglLVc is required
for the glycosylation of multiple V. cholerae proteins, including periplasmic chaperones
such as DegP, that are required for efficient type II-dependent secretion. Moreover,
defined deletion mutants and complementation strains provided first insights into the
physiological role of O-linked protein glycosylation in V. cholerae. RbmD, a protein
with structural similarities to PglLVc and other established oligosaccharyltransferases
(OTases), was also included in this phenotypical characterization. Remarkably, presence
or absence of PglLVc and RbmD impacts the secretion of proteins via the type II
secretion system (T2SS). This is highlighted by altered cholera toxin (CT) secretion,
chitin utilization and biofilm formation observed in 1pglLVc and 1rbmD single or double
mutants. This work thus establishes a unique connection between broad spectrum
O-linked protein glycosylation and the efficacy of type II-dependent protein secretion
critical to the pathogen’s lifecycle.
Keywords: post-translational modification, O-OTase, Vibrio cholerae, biofilm, virulence, chaperone
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PglC, and PglD are required for synthesis of Und-PP linked
di-N-acetyl bacillosamine (diNAcBac), the proximal sugar in
the oligosaccharide (Aas et al., 2007; Hartley et al., 2011). The
fully synthesized glycan is flipped to the periplasmic space by the
flippase PglF and subsequently transferred by the OTase PglL/O
on diverse target proteins via en block transfer (Aas et al., 2007;
Vik et al., 2009).
Intrigued by a potential, intrinsic V. cholerae posttranslational modification system (Gebhart et al., 2012), we
constructed and characterized a pglLVc null mutant. Using
a reverse glycoengineering strategy, we found that PglLVc is
required for the glycosylation of multiple V. cholerae proteins.
In addition, the pglLVc null mutant showed altered biofilm
features and a trend toward enhanced type II substrate secretion.
Remarkably, these phenotypes were significantly augmented
in a background simultaneously lacking RbmD, a protein of
unknown function with limited structural similarities to PglLVc
and other established oligosaccharyltransferases (Supplementary
Figure S1). Thus, this work reveals genetic interactions between
pglLVc and rbmD, and establishes clear connections between
broad spectrum O-linked protein glycosylation and secretion
processes important in diverse pathogen life styles.

INTRODUCTION
The Gram-negative pathogen Vibrio cholerae, the causative agent
of the severe secretory diarrheal disease cholera, transits between
two dissimilar habitats along its life cycle. V. cholerae efficiently
colonizes the human gastrointestinal tract upon oral ingestion
of contaminated food or water, but also persists as a natural
inhabitant in aquatic ecosystems during inter-epidemic periods
(Schild et al., 2008; Nelson et al., 2009). V. cholerae employs
a number of strategies to quickly adapt to the differential
conditions faced along its life cycle, which ensures survival even
under unfavorable conditions.
A hallmark of environmental survival and transmission of
V. cholerae is the ability to form biofilms on chitinous surfaces
in the aquatic reservoirs. Ubiquitous chitin particles in the
nutrient-limited aquatic reservoir not only act as an attachment
platform for subsequent biofilm formation, but also serve as a
carbon and nitrogen source. Accordingly, V. cholerae expresses
a complex chitin utilization program including several secreted
chitinases (Meibom et al., 2004). Once ingested by humans,
V. cholerae passes the acidic barrier in the stomach and reaches
the small intestine, the primary site of colonization. During
this passage, V. cholerae activates a complex regulatory cascade
to induce the expression of virulence factors and achieve full
colonization fitness (Childers and Klose, 2007). The pathology
of cholera is mainly due to the activity of the secreted cholera
toxin (CT), which induces a massive efflux of chloride ions and
water into the intestinal lumen resulting in a secretory diarrhea
(Childers and Klose, 2007).
Several proteins crucial for survival fitness along the different
stages of the life cycle are secreted via the type II secretion system
(T2SS). These include CT, the biofilm matrix proteins (RbmA,
RbmC, and Bap1), and chitinases along with complementary
proteins involved in chitin metabolism (Sikora et al., 2011;
Johnson et al., 2014). Adaptation to different conditions has so
far been mainly investigated through transcriptional profiling,
although there is growing evidence that V. cholerae also takes
advantage of post-translational regulatory strategies. These are
exemplified by proteolysis control of transcription factors TcpP
and ToxR affecting virulence factor expression, RpoS responsible
for the mucosal escape response and FliA, which inversely
controls flagella gene transcription and virulence gene expression
(Matson and DiRita, 2005; Nielsen et al., 2006; AlmagroMoreno et al., 2015; Pressler et al., 2016; Rogers et al., 2016;
Wurm et al., 2017).
O-linked protein glycosylation appears to be widely
distributed in bacteria and represents a post-translational
modification whereby oligosaccharyltransferases (OTases)
transfer a pre-assembled glycan onto target proteins (Iwashkiw
et al., 2013). Based on current models for Gram-negative bacteria,
the glycan is synthesized on an undecaprenyl pyrophosphate
(Und-PP) lipid carrier in the cytoplasm, flipped across the
inner membrane and utilized by O-OTases to glycosylate
serine or threonine residues of target proteins in the periplasm
(Nothaft and Szymanski, 2010). Probably the best studied
O-glycosylation system of Gram-negative bacteria is the protein
glycosylation (pgl) in Neisseria gonorrhoeae. Briefly, PglB,
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MATERIALS AND METHODS
Strain Construction and Growth
Conditions
Bacterial strains and plasmids or oligonucleotides used in this
study are listed in Tables 1, 2, respectively. The clinical isolate
V. cholerae O1 El Tor C6709 was used as WT strain in all
experiments. Escherichia coli strains DH5αλpir and SM10λpir
were used for genetic manipulations. Unless stated otherwise,
all strains were grown with aeration in lysogeny broth (LB, 1%
tryptone; 1% NaCl; 0.5% yeast extract) on 37◦ C, on LB agar
plates at 37◦ C, or for biofilm formation under static conditions at
24◦ C. To assess CT expression and secretion, V. cholerae strains
were grown under virulence gene inducing conditions at 37◦ C
for 4 h anaerobically using AKI broth, followed by 4 h aerobic
growth with shaking at 180 rpm (Iwanaga and Yamamoto,
1985; Iwanaga et al., 1986). Minimal media M9 was prepared
according to standard recipe (Miller, 1972), and is indicated
as M9-X, whereby X represents the sole carbon source used.
Antibiotics and other supplements were used in the following
final concentrations: streptomycin (Sm, 100 µg/ml), ampicillin
(Ap, 50 µg/ml in combination with other antibiotics, otherwise
100 µg/ml), kanamycin (Km, 50 µg/ml), chloramphenicol (Cm,
20 µg/ml for E. coli strains or 2 µg/ml for V. cholerae strains),
sucrose (10%), glucose (Glc, 0.2%), chitin (0,2%, Sigma-Aldrich),
N-acetylglucosamine (GlcNAc, 0.2%).

DNA Manipulations, Construction of
Suicide Plasmids, Reporter Fusions,
Mutant Strains, and Expression Plasmids
Qiaquick Gel extraction and Qiaquick PCR Purification kits
(Qiagen) were used for purifying PCR products and digested
R

2

R
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TABLE 1 | Strains and plasmids used in this study.
Strain description

References

DH51λpir

F-φ(lacZYA-argF) U169recA1endA1 hsdR17 supE44 thi-1 gyrA96 relA1λ:pir

Kolter et al., 1978

SM10λpir

thi recA thr leu tonA lacY supE RP4-2-Tc:Muλ:pir

Miller and Mekalanos, 1988

CLM24

Constructed from E. coli W3110 (IN(rrnD-rrnE)1 rph-1). waaL mutant

Feldman et al., 2005
Roberts et al., 1992

E. coli

V. cholerae
WT

C6709, O1 El Tor Inaba, clinical isolate, 1991 Peru, tcpA+ ctxAB+ hapR+ , spontaneous Smr

C6709lacZ

C6709, lacZ:res-neo-sacB-res

Tamayo et al., 2008

1pglLVc

Deletion of pglLVc (VC0393) in C6709, Smr

This work

1rbmD

Deletion of rbmD (VC0931) in C6709, Smr

This work

1rbmA

Deletion of rbmA (VC0928) in C6709, Smr

This work

1pglLVc 1rbmD

Deletion of pglLVc and rbmD in C6709, Smr

This work

1pglLVc 1rbmD1rbmA

Deletion of pglLVc , rbmD and rbmA in C6709, Smr

This work

1degP:cat

Deletion of degP (VC0566) in C6709, Smr , Cmr

This work

1pglLVc 1rbmD 1degP:cat

Deletion of pglLVc , rbmD and degP in C6709, Smr , Cmr

This work

1epsC-N

Deletion of epsC-N (VC2734-VC2723) in C6709, Smr

This work

1hapR

Deletion of hapR in C6709, Smr

Seper et al., 2011

vpsA:phoA

Insertion of pGPphoA in vpsA of C6709, Smr , Apr

Seper et al., 2011

1hapRvpsA:phoA

Insertion of pGPphoA in vpsA of 1hapR, Smr , Apr

Seper et al., 2011

1pglLVc 1rbmD vpsA:phoA

Insertion of pGPphoA in vpsA of 91pglLVc 1rbmD, Smr , Apr

This work

1lacZ:gfp

Insertion of gfp in the lacZ of C6709, Smr

This work

1pglLVc 1lacZ:gfp

Insertion of gfp in the lacZ of 1pglLVc , Smr

This work

1rbmD1lacZ:gfp

Insertion of gfp in the lacZ of 1rbmD, Smr

This work

1pglLVc 1rbmD1lacZ:gfp

Insertion of gfp in the lacZ of 1pglLVc 1rbmD, Smr

This work

1vps-I:Km

Deletion of vps-I cluster (VC0917-VC0927) in C6709 by exchange with a kanamycin cassette, Smr ,
Kmr

This work

1vps-I

Deletion of kanamycin cassette in 1vps-I:Km, Smr

This work

1pglLVc 1rbmD1vps-I:Km

Deletion of vps-I cluster (VC0917-VC0927) in 1pglLVc 1rbmD by exchange with a kanamycin
cassette, Smr , Kmr

This work

1pglLVc 1rbmD1vps-I

Deletion of kanamycin cassette in 1pglLVc 1rbmD1vps-I:Km, Smr

This work

1rfb:Km

Deletion of rfbA to rfbU (VC0241-VC0260) in C6709 by exchange with a kanamycin cassette, Smr ,
Kmr

This work

1rfb

Deletion of kanamycin cassette in 1rfb:Km, Smr

This work

pCVD442

ori6K mobRP4 sacB, Apr

Donnenberg and Kaper, 1991

pJZ111

Plac:gfp:lacZ in pCVD442, Apr

Seper et al., 2014

p

pMMB67EH, IncQ broad-host-range low-copy-number cloning vector, IPTG inducible, Apr

Morales et al., 1991

pMMBneo

pMMB67EH-based plasmid, IncQ broad-host-range low-copy-number cloning vector, IPTG
inducible, Kanr

Tamayo et al., 2008

pQE60

C-terminal His-tag expression plasmid, Apr

Qiagen

pAC1000

Cmr

Hava et al., 2003

pACYC184

Cloning and expression vector, p15A ori, IPTG inducible, derived from pACT3, Cmr

Chang and Cohen, 1978

pACYCpglFBCD

pACYC184-based plasmid containing the pglFBCD locus from N. gonorrhoeae, Cmr

Egge-Jacobsen et al., 2011

pGPphoAvpsA

pGPphoA with “vpsA” fragment of C6709, Apr

Seper et al., 2011

pCVD1pglLVc

pCVD442 with up- and downstream fragments of pglLVc , Apr

This work

pCVD1rbmD

pCVD442 with up- and downstream fragments of rbmD, Apr

This work

pCVD1rbmA

pCVD442 with up- and downstream fragments of rbmA, Apr

This work

pCVD1degP:cat

pCVD442 with up- and downstream fragments of degP flanking a cat cassette, Apr , Cmr

This work

pCVD1epsC-N:cat

pCVD442 with upstream fragment of epsC and downstream fragment of epsN flanking a cat
cassette, Apr , Cmr

This work

p-pglLVc

pglLVc of V. cholerae in pMMB, Apr

This work

p-rbmD

rbmD of V. cholerae in pMMB, Apr

This work

pMMBneo-pglLVc

pglLVc of V. cholerae in pMMBneo, Kmr

This work

pMMBneo-rbmD

rbmD of V. cholerae in pMMBneo, Kmr

This work

Plasmids

(Continued)
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TABLE 1 | Continued
Strain description

References

pMMB-degP

degP of V. cholerae in pMMB, Apr

pQE60-rbmA

rbmA of V. cholerae in pQE60, Apr

pQE60-degP

degP of V. cholerae in pQE60, Apr

This work

pCVD1vpsA:KanI

pCVD442 with upstream and downstream fragment of vpsA flanking 2/3 of a kanamycin resistance
cassette, Apr , Kmr

This work

This work

pGPvpsK:KanII

pGP704 with a fragment of vpsK flanking 2/3 of a kanamycin resistance cassette, Apr , Kmr

This work

pCVD1vpsA-K

pCVD442 with an upstream fragment of vpsA and a downstream fragment of vpsK, Apr , Kmr

This work

pCVD1rfbA:KanI

pCVD442 with upstream and downstream fragment of rfbA flanking 2/3 of a kanamycin resistance
cassette, Apr , Kmr

Schild et al., 2005

pGPrfbU:KanII

pGP704 with a fragment of rfbU flanking 2/3 of a kanamycin resistance cassette, Apr , Kmr

This work

pCVD1rfbA-U

pCVD442 with an upstream fragment of rfbA and a downstream fragment of rfbU, Apr , Kmr

This work

sequence of vpsK and the last two-thirds (C0 terminal) of
the 0 kanR gene (KanII) was constructed. The PCR fragments
were obtained using the oligonucleotide pairs vpsK_NcoI and
vpsK_XbaI for 800 bp downstream of vpsK or KanII_SacI and
KanII_NcoI for KanII (Schild et al., 2005) (Table 2), digested
with Xba/NcoI or NcoI/SacI, and ligated into a SacI/XbaIdigested pGP704, resulting in pGPvpsK:KanII. After conjugation
of pGPvpsK:KanII in C67091vpsA:KanI, we obtained Apr
colonies. Colony purification of some of these cells in absence
of Ap and subsequent selection for Kmr resulted in Kmr /Aps
colonies. Deletion of kanamycin cassette was achieved by a
pCVD442 suicide vector mutagenesis using pCVD1vpsA-K,
which constructed by amplifying PCR fragments using the
oligonucleotide pairs vpsA_SacI_1 and vpsA_NcoI as well as
vpsK_NcoI and vpsK_XbaI, digested with Xba/NcoI or NcoI/SacI,
and ligated into a SacI/XbaI-digested pGP704, resulting in
pGPvpsK:KanII. The correct chromosomal deletion of genes
vpsA-K was confirmed by PCR.
The 1rfb deletion mutant was generated as described above
(see 1vps-I deletion mutant construction for details) and
comprises a deletion spanning from rfbA to rfbU (VC0241VC0260). This required the pCVD1rfbA:KanI (Schild et al.,
2005) and pGPrfbU:KanII (Table 2). The latter was constructed
by amplifying PCR fragments using the oligonucleotide pairs
rfbU_BamHI and rfbU_XbaI for 800 bp downstream of rfbU
or KanII_SacI and KanII_BamHI for KanII (Schild et al.,
2005) (Table 2), digested with Xba/BamHI or BamHI/SacI,
and ligated into a SacI/XbaI-digested pGP704, resulting in
pGPrfbU:KanII. Deletion of kanamycin cassette was achieved
by a pCVD442 suicide vector mutagenesis using pCVD1rfbAU, which was constructed by amplifying PCR fragments using
the oligonucleotide pairs rfbA_SacI_1 and rfbA_BamHI as well
as rfbU_BamHI and rfbU_XbaI, subsequent digestion with
SacI/BamHI/or BamHI/XbaI, and ligation into a SacI/XbaIdigested pGP704, resulting in pGPrfbU:KanII. The correct
chromosomal deletion of genes rfbA-U was confirmed by PCR.
Construction of 1epsC-N mutant was done as previously
described by Sikora et al. (2007) using the appropriate
oligonucleotide pairs listed in the Table 2.
All expression plasmids were constructed in a similar
manner. PCR fragments of the respective genes containing
their own ribosomal binding sites were generated using

plasmid DNA. PCR reactions for subcloning were carried out
using the Q5 High-Fidelity DNA Polymerase (NEB), whereas
Taq DNA Polymerase (NEB) was used for all other PCRs. Plasmid
DNA was isolated using plasmid DNA purification kits (Qiagen).
Constructions of in frame deletion mutants were carried out
as described by Donnenberg and Kaper (1991). 800 bp long
DNA fragments flanking the gene of interest were amplified using
the oligonucleotide pairs x_y_1 and x_y_2 or x_y_3 and x_y_4,
where x represents the gene and y the restriction site/enzyme
used (Table 2). For the construction of pCVD1degP:cat the catfragment was additionally amplified using pAC1000 as template
and the oligonucleotide pairs cat_EcoRI_fw and cat_EcoRI_rev.
After digestion with the appropriate restriction enzyme, indicated
by the name of oligonucleotide, PCR fragments were ligated
into pCVD442 restricted with similar restriction enzymes (NEB).
Obtained corresponding knockout plasmids are listed in Table 1.
Generated plasmids were first transformed into E.coli Sm10λpir
and mobilized into V.cholerae via conjugation. Exconjugants
were purified by Smr and Apr selection, followed by sucrose
selection, as previously described (Donnenberg and Kaper, 1991).
Correct chromosomal deletions were confirmed by PCR. GFP
expressing strains were generated by insertion of gfp in the lacZ
locus using the suicide plasmid pJZ111 (Seper et al., 2014).
For the construction of 1vps-I deletion mutant a method
by Schild et al. (2005) was used, which enabled us to remove
a relatively large chromosomal gene cluster (VC0917-VC0927).
Briefly, the first step was the construction of a vpsA mutant
carrying an insertion of the kanR’ gene (originating from
plasmid pACYC177), consisting of about two-thirds of its
gene length (KanI), and including the promoter and ShineDalgarno sequences. 800 bp long upstream and downstream
sequences of vpsA were amplified by PCR using oligonucleotide
pairs vpsA_SacI_1 and vpsA_BamHI_2 or vpsA_EcoRI_3 and
vpsA_XbaI_4 (Table 2). The 800-bp PCR fragment of KanI
was generated using the oligonucleotide pairs kanI_BamHI and
kanI_EcoRI (Schild et al., 2005). The three PCR fragments
were digested with appropriate restriction enzymes (NEB) and
ligated together into a SacI/XbaI-digested pCVD442, resulting in
the plasmid pCVD1vpsA:KanI. The plasmid pCVD1vpsA:KanI
was mobilized into V. cholerae via conjugation, obtaining
the mutant C67091vpsA:KanI after sucrose selection. In the
second step, the suicide plasmid pGP704 harboring downstream
R
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pMMB67EH, pMMBneo or pQE60. Expression constructs
were transformed into DH5αλpir, and Apr colonies were
characterized by colony PCR.

TABLE 2 | Oligonucleotides used in this study.
Primer name

Sequence (50 –30 )a

VC0393_XbaI_1

AGGTCTAGAACACTTTGATA

VC0393_EcoRI_2

AAAGAATTCCACCTTAAAAAAGAAACCA

Immunoprecipitation

VC0393_EcoRI_3

AATGAATTCTAAGCTCTGCGAGAAACA

VC0393_SacI_4

AATGAGCTCTAGCGAAGCAGCATGG

Immunoprecipitation was performed using Dynabeads
Protein G Immunoprecipitation Kit (Invitrogen) according to
manufacturer’s manual. 4 µl of npg1 antibody was incubated with
196 µl of binding and washing buffer and subsequently bound
to the Dynabeads. Periplasmic protein fractions of respective
strains were precipitated using ammonium sulfate and 200 µg of
protein in 500 µl sample buffer was used as antigen. Proteins in
the immunoprecipitations were incubated in 5× Laemmli buffer
for 10 min at 100◦ C, separated with SDS-PAGE and analyzed by
mass spectrometry.

VC0931_SacI_1

AAGAGCTCCAAATTATTTAACAAGCCACA

VC0931_BamHI_2

AAGGATCCCATAAATTCGGTGGCTCAA

VC0931_BamHI_3

TTGGATCCTGATTGCTCTTCATCTCC

VC0931_XbaI_4

TTTCTAGACACGGCAACACTTTGGG

VC0928_XbaI_1

TTTTCTAGAGCTAAGTTGGCTAAT

VC0928_EcoRI_2

TTTGAATTCCAACCATTTGTTTTTACAACT

VC0928_EcoRI_3

TTTGAATTCTAAATTTACCTAGTCACTTAG

VC0928_SacI_4

TTAGAGCTCACTACAACACAAGCGACA

VC0566_Xbal_1

TTATCTAGAAGGTCGTACCACTGGCT

VC0566_EcoRI_2

AAAGAATTCATAAGCTCCTCAACAAATTAA

VC0566_EcoRI_3

AATGAATTCTAATTATCACTCAGCGTTACC

VC0566_SacI_4

TTTGAGCTCGGTGGCTTGTTGAAAAGA

VC0393_SacI_pMMB_fw

TTGAGCTCGAACTGTGCGCTGGTTTC

VC0393_SphI_pMMB_rev

TTGCATGCCACCCTTATTGTTTCTCG

VC0931_EcoRI_pMMB_fw

TTGAATTCCTATTTTGAGCCACCGAA

VC0931_BamHI_pMMB_rev

TTGGATCCAGTGATCATGCAGGAGAT

VC0928_NcoI_pQE60_fw

AAACCATGGACAAACGTCATTATTATCTGG

VC0928_BglIII_pQE60_rev

TTTAGATCTTTTTTTTACCACTGTCATTGA

VC0566_NcoI_pQE60_fw

TAACCATGGAAAAACCTTTACTTGTTTTAACT

VC0566_BamHI_pQE60_rev

TTAGGATCCACGAACAACCAAGTAAAGCGT

VC2734_SacI_1

AAAGAGCTCGCCTTGCTTAGGTTCA

VC2734_BamHI_2

TTAGGATCCCATAAATTTCCACGTTATTCC

VC2723_EcoRI_3

AATGAATTCTAGGATGTGTAATCCCATTCA

VC2373_XbaI_4

TTTTCTAGATCATTCGCTGGCCTTTA

cat_EcoRI_fw

TTTGAATTCGATAAGCTTGATGAAAATTTG

cat_EcoRI_rev

TTAGAATTCAGGTTAGTGACATTAGAAAA

vpsA_SacI_1

TTGAGCTCTAGTCGTGTGTACAGGTAATT

vpsA_BamHI_2

TTCCTAGGCACTTCCCCACATCCTCT

vpsA_EcoRI_3-1

TTGAATCCTACTTCCCGAGTAGGCACAA

vpsA_XbaI 4-1

ATTCTAGAGAAACCAACTCGATA

vpsA_NcoI

TTCCATGGCACTTCCCCACATCCTCT

vpsK_NcoI

AATCCATGGTATGGGGGTGGTTT

vpsK_XbaI

AAATCTAGAAAAATACATCCGCTTTTATT

rfbA_SacI

TTGAGCTCGATGTTTATACCTGTAATTATGGCT

rfbA_BamHI

TAGGATCCACTGGCTAAATACTGCTCAGCAA

rfbU_BamHI

AAAGGATCCAAATAAAGAGAGAAAGTCTCC

rfbU_XbaI

AATCTAGAATGTCTTAGGCTCTTCAGGT

kanI_BamHI

ATGGATCCTTCAACTCAGCAAAAGT

kanI_EcoRI

TAGAATTCCGACTCGTCCAACATCAATA

kanII_SacI

TAGAGCTCATGGATGCGTATTTATATGGGT

kanII_BamHI

TCGGATCCGTCAGCGTAATGCTCTGCCAGT

kanII_NcoI

TCCCATGGTCAGCGTAATGCTCTGCCAGT

a Restriction

R

SDS-PAGE and Immunoblot Analysis
To separate proteins the standard sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) procedure was
used with 12 or 15% gels and the Prestained Protein Marker
Broad Range (New England Biolabs) as a molecular mass
standard. Proteins were visualized by conventional colloidal
Coomassie staining according to Kang et al. (2002) or transferred
to a nitrocellulose membrane (Amersham) for immunoblot
analysis using mouse anti-His antisera (Qiagen, 1:2,000 diluted
in 3% BSA) for detection of His-tagged proteins, anti-CT
antisera (Sigma-Aldrich, 1:5,000 diluted in 10% skim milk),
npg1 (1:10,000 diluted in 10% skim milk) or rabbit anti-BSA
antisera (Thermo Fisher Scientific, 1:2,000 diluted in 3.7% soy
milk) as primary antibodies. Peroxidase-conjugated goat antimouse (Dianova GmbH, diluted 1:7,500 in 10% skim milk) or
peroxidase conjugated goat anti-rabbit (Dianova GmbH, 1:7,500
in 10% skim milk or 1:7,500 diluted in 3.7% soy milk in case of
BSA detection) were used as secondary antibodies. Loading of
equal amounts proteins was achieved by Bradford quantification
and verified by Kang staining of SDS-PAGE gels in parallel
to the immunoblot analysis. Chemiluminescence detection was
performed by incubating the membrane in an ECL solution (BioRad Laboratories) with subsequent exposure in a ChemiDoc XRS
system (Bio-Rad Laboratories) in combination with the Quantity
One software (Bio-Rad Laboratories).

His-Purification of Proteins Using
Immobilized Metal Ion Affinity
Chromatography
Proteins with C-terminal His-tag were purified using a Ni
SepharoseTM Fast Flow (GE Healthcare) according to the
manufacturer’s manual for batch purification. Briefly, appropriate
amounts of V. cholerae cultures grown over night (ON) were
inoculated in fresh LB to an OD600 of 0.1, grown to and
OD600 of 0.5 following induction with IPTG (1 mM) for
6 h at 37◦ C. Cells were pelleted for 30 min at 17,000 × g
and pellets were stored at −20◦ C. On the following day,
pellets were thawed in 5 ml lysis buffer (150 mM NaCl,
50 mM Tris–HCl pH 7.5, 1% Triton-X) with the addition of
protease inhibitor cocktail tablet (cOmpleteTM , Roche). After

sites are underlined.

the oligonucleotide pairs x_y_z_fwd and x_y_z_rev, where x
represents the gene, y the restriction site/enzyme used and z
the respective expression plasmid (Table 2). PCR fragments
digested with the respective restriction enzymes were ligated
into the similarly digested IPTG-inducible expression vectors
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sonification to lyse the cells, the soluble fraction was collected
by centrifugation (30 min, 17,000 × g) and filtered through
a syringe filter (0.45 µm). The resin was washed once with
ddH2 O and twice with binding and washing buffer pH 7.4
(81 mM Na2 HPO4 , 19 mM NaH2 PO4 , 0.5 M NaCl, 30 mM
imidazole). Finally, 1 ml 50% Ni Sepharose slurry was added
to 5 ml sample and incubated 1 h at 4◦ C with rotation. To
wash the unbound protein, Ni Sepharose/sample was incubated
three times 2 min with 1 mL binding and washing buffer on
a rocker. Each time, Ni Sepharose/sample was collected by
centrifugation 5 min at 500 × g. His-tagged protein was eluted
stepwise with 500 µL elution buffer containing 100 mM, 200,
300or 500 mM imidazole, respectively. Each elution step was
performed for 30 min at 4◦ C with rotation. All fractions were
collected in the separate tubes and subjected to SDS-PAGE and/or
immunoblot analyses.

PTM Analysis by Mass Spectrometry
Kang stained protein bands of affinity purified DegP was washed,
de-stained and digested with both trypsin and GluC as previously
described (Anonsen et al., 2012). Dried samples were redissolved
in 0.1% FA prior to LC-MS/MS analysis. The LC-MS/MS analysis
was performed as for protein analysis by MS with the following
modification: Solvent B was changed to 90% ACN/9.9% H2 O
containing 0.1% FA. The column temperature was set at 40◦ C.
The separation gradient was modified to, 0–3 min: 3% B; 3–
53 min: 3–55% B; 55–59 min: 80% B, 60.3–63.3 min: 3% B. The
sample was ionized in the nanospray source and analyzed in an Q
Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific,
Waltham, MA, United States). Mass spectra were acquired in the
positive ion mode applying alternating full scan MS (m/z 200–
2,000) at a resolution of 70000 (at m/z 400) and MS/MS by HCD
with NCE@28 of the 12 most intense peaks at a resolution of
17500 (at m/z 400) with dynamic exclusion for 30 s. Generated
mass spectra were analyzed with the DegP protein sequence.
Glycopeptides mass spectra were extracted based on the presence
of the three diNAcBac reporter ions at m/z 229.118, at m/z
211.107 and at m/z 169.096 using Thermo Xcalibur (version
3.0.63) and manually assigned to DegP peptide sequences.

Protein Analysis by Mass Spectrometry
Protein bands excised from the SDS gel were reduced, alkylated
and digested with Promega modified trypsin according to
the method of Shevchenko et al. (1996). Peptide extracts
were dissolved in 0.1% formic acid (FA), 5% acetonitrile
(ACN) and separated by nano-HPLC (Dionex Ultimate 3000)
equipped with an enrichment column (C18, 5 µm, 100 Å,
5 × 0.3 mm) and an Acclaim PepMap RSLC nanocolumn
(C18, 2 µm, 100 Å, 500 × 0.075 mm) (all Thermo Fisher
Scientific, Vienna, Austria). Samples were concentrated on the
enrichment column for 6 min at a flow rate of 5 µl/min
with 0.1% formic acid as isocratic solvent. Separation was
carried out on the nanocolumn at a flow rate of 250 nl/min
at 60◦ C using the following gradient, where solvent A is
0.1% formic acid in water and solvent B is acetonitrile
containing 0.1% formic acid: 0–6 min: 4% B; 6–94 min:
4–25% B; 94–99 min: 25–95% B, 99–109 min: 95% B;
109.1–124 min: 4% B; The sample was ionized in the
nanospray source equipped with stainless steel emitters (ES528,
Thermo Fisher Scientific, Vienna, Austria) and analyzed in
an Orbitrap velos pro mass spectrometer (Thermo Fisher
Scientific, Waltham, MA, United States) operated in positive
ion mode, applying alternating full scan MS (m/z 400–
2,000) in the ion cyclotron and MS/MS by CID of the
20 most intense peaks with dynamic exclusion enabled.
The LC-MS/MS data were analyzed by searching a database
containing all V. cholerae sequences of the Uniprot database
(downloaded on December 5th, 2016, 92555 sequences) and
all common contaminants with Proteome Discoverer 1.4
(Thermo Fisher Scientific) and Mascot 2.4.1 (MatrixScience,
London, United Kingdom). Carbamidomethylation on cysteine
was entered as fixed and oxidation on methionine and 2,4diacetamido-2,4,6-trideoxyhexose (DATDH) with a mass of
228.111 Da on serine as variable modification. Detailed search
criteria were used as follows: semitrypsin; max. missed cleavage
sites: 2; search mode: MS/MS ion search with decoy database
search included; precursor mass tolerance ±10 ppm; product
mass tolerance ±0.7 Da; acceptance parameters: 1% false
discovery rate (FDR); only rank 1 peptides; minimum Mascot ion
score 20; minimum 2 peptides per protein.
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Alkaline Phosphatase Assays
To determine the enzymatic activities for the transcriptional
phoA fusions, alkaline phosphatase assays were performed as
described previously (Manoil, 1991). Bacterial cultures were
grown to mid-log phase (∼OD600 = 0.5) in LB media at
24◦ C. The activities were expressed in Miller units, given by
(A405 × 1,000)/(A600 × ml × min).

Static Biofilm Assay With Crystal Violet
Staining
Biofilm assays under static conditions were essentially performed
as previously described (Seper et al., 2011). Briefly, the respective
strains were grown ON) in LB-Sm or LB-Ap/Glc liquid media
(for plasmid containing strains). On the following day, a fresh
culture LB-Sm or LB-Ap/IPTG (in case of strains harboring
pMMB67EH or its derivatives), was adjusted to an OD600 = 0.01
and inoculated in a 96 well microtiter plate (U bottom, Sterilin).
Biofilm was grown in a 24◦ C climate chamber for 24, 48 or
72 h. Wells were subsequently rinsed using a microplate washer
(anthos Mikrosysteme GmbH, Fluido2). Biofilm was stained with
0.1% crystal violet, solubilized in 96% ethanol and the OD595 was
measured (microplate reader: BMG Labtech SPECTROstarNano )
to quantify the amount of biofilm.

Flow Cell Biofilm Experiments
For visualization and quantification of dynamically formed
biofilm, a three channel flow cell system using 2% LB-Sm broth
(24 h, RT) was used as described previously (Seper et al.,
2011, 2014; Pressler et al., 2016). The respective GFP expressing
V. cholerae strains were used for biofilm formation to allow
acquisition of fluorescent images with confocal laser scanning
microscopy. A coverslip 24 × 50 mm (Menzel-Glaeser) was used
as substratum for biofilm growth. The respective ON cultures
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compared to whole cell extracts (WCE). This indicates equally
low levels of cytoplasmic contamination for all periplasmic
fractions used for ELISA.

were adjusted to OD600 = 0.1 using 2% LB Approximately
300 µl of the dilutions were inoculated per channel. After static
incubation for 2 h at RT, initial attachment of cells to the abiotic
surface was analyzed in the attachment assay. For analysis of
mature biofilm, the static incubation for 2 h at RT was followed by
a constant flow of 2% LB at the rate of 3 ml h−1 for 22 h. Images
of attached bacteria or biofilms were recorded by confocal laser
scanning microscopy.

Dot Blot Analysis
Dot blot analyses was essentially performed as described recently
using a 96-well Whatman Minifold I Dot-Blot System (GE
Healthcare) (Roier et al., 2016). Briefly, equal protein amounts
(according to Bradford) of periplasmic factions or dilutions (3fold steps) thereof were spotted onto a nitrocellulose membrane.
Dilutions (3-fold steps) of a whole cell extract derived from the
WT served as positive control (for details see section “Generation
of Whole Cell Extracts”). Then, each membrane was dried,
incubated in TBS (20 mM Tris/HCl, pH 7.5, 150 mM NaCl) for
2 min, and blocked in 10% skim milk in TBS for 2 h. Afterward,
the membrane was incubated with a monoclonal antibody
to the α-subunit of the RNA polymerase (RpoA, NeoClone
Biotechnology, diluted 1:2,000 in 10% skim milk) overnight. The
next day, membranes were washed three times in TBS for 10 min,
incubated with the secondary antibody (horseradish peroxidaseconjugated goat anti-mouse IgG antibody from Dianova, diluted
1:7,500 in 10% skim milk in TBS) for 2 h, washed once in TBST (20 mM Tris/HCl, pH 7.5, 250 mM NaCl, 0.05% Tween-20),
and twice in TBS for 10 min each. Finally, chemiluminescence
detection was performed as described above (for details see
section “SDS-PAGE and Immunoblot Analysis”).

Confocal Laser Scanning Microscopy
Images of biofilms were acquired using a Leica SP5 confocal
microscope (Leica Microsystems, Mannheim, Germany) with
spectral detection and a Leica HCX PL APO CS 63x water
objective (NA 1.2). Optical sectioning was performed in 0.13 µm
steps. GFP was excited at 488 nm, fluorescence emission was
detected between 500 and 560 nm, and images were recorded
without differential interference contrast (DIC) optics. For
visualization and processing of image data the Leica LAS AF
Lite and ImageJ 1.46 software was used. Quantification and
morphological analysis of image stacks was performed using
the computer program COMSTAT1 (Heydorn et al., 2000;
Vorregaard, 2008).

Cell Fractionation
A cell fractionation was performed essentially as described by
Neu and Heppel (1965). Briefly, V. cholerae cultures grown
ON were inoculated in fresh LB to an OD600 of 0.1, grown
until OD600 of 0.5 and subsequently induced with 1 mM IPTG
for 4 h. Supernatant (SUP) of the culture was collected by
centrifugation 10 min, 5,000 × g and filter-sterilized using a
0.22 µm syringe filter. In parallel, cell equivalents reflecting 1 l
of a culture with OD600 of 1 were pelleted by centrifugation
(10 min, 5,000 × g) and washed in buffer 20 mM Tris–
HCl pH 8. After another round of centrifugation, cells were
resuspended in 20% sucrose and 1 mM Na-EDTA and incubated
for 10 min. Cells were then centrifuged for 10 min, 5,000 × g
at 4◦ C and resuspended in ice cold 0.5 mM Mg2 SO4 by slow
pipetting. The combination of cold temperature and hypotonic
solution caused the burst of the bacterial outer membrane and
release of the periplasmic fraction (PF) in the supernatant.
After incubation for ∼5 min, samples were centrifuged for
5 min, 10,000 × g at 4◦ C to remove cell debris and intact
cells. The supernatant was recovered as the periplasmic fraction.
Periplasmic fractions were directly used for CT quantification
by ELISA, while in all other cases proteins in the collected
SUP and PF were either precipitated using trichloroacetic acid
(TCA)/acetone for immunoblot analyses or ammonium sulfate in
case of immunoprecipitation. In case of ELISA and immunoblot
analyses, periplasmic fractions were controlled for cytoplasmic
contamination and cell lysis via dot blot analyses detecting RpoA,
the α-subunit of the RNA-Polymerase (for details see section
“Dot Blot Analysis”). A representative dot blot is shown in
Supplementary Figure S4A. In general, similar intensities for
periplasmic fractions used for ELISA were observed. Moreover,
intensities in all periplasmic fractions were magnitudes lower
1

Precipitation of Proteins Using
TCA/Acetone
Protein precipitation using TCA and acetone was essentially
performed as described by Link and LaBaer (2011), with
following modifications. Samples were spiked with BSA
(0.1 µg/ml), before a solution of 100% TCA was added to the
protein samples (SUP or the PF) to the final TCA concentration
of 20%. Samples were mixed and stored ON at −20◦ C. On the
next day, samples were thawed and centrifuged 30,000 × g for
1 h. Supernatant was carefully decanted and 20 ml of acetone was
added to the pellet. Samples were again centrifuged 30,000 × g
for 1 h. A second washing step with 20 ml of acetone was
performed with the final centrifugation step of 50,000 × g.
After decanting the supernatant, pellets were air-dried for
30 min and subsequently suspended in 200 µl of PBS buffer. In
attempt to completely dissolve the pellet, samples were placed
in a sonification bath for 30 min. Undissolved particles were
removed by short centrifugation. Concentration of proteins was
determined with Bradford assay (BioRad). Similar efficiency of
protein precipitation using TCA was controlled by immunoblot
analyses detecting BSA (for details see section “SDS-PAGE and
Immunoblot Analysis”).

Precipitation of Proteins Using
Ammonium Sulfate
Periplasmic protein content was also subjected to precipitation
using ammonium sulfate, which yields a relatively soluble
protein extract essential for immunoprecipitation. Following cell
fractionation, ammonium sulfate was added to the periplasmic

http://www.comstat.dk
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and purified CT for 1 h at RT and were washed again as
described above. After incubation with the primary antibody
(Sigma-Aldrich, anti-CT antibody), diluted 1:10,000 in BSAPBS for 1 h at RT, ELISA plates were washed four times with
PBS-T. After incubation with the secondary antibody (Dianova
GmbH, peroxidase conjugated goat anti-rabbit), diluted 1:2,000
in BSA-PBS for 1 h at RT and subsequent washing, the
ELISA plates were incubated with TMB Substrate Reagent Set
(BioLegend, Vienna) for detection of CT. The reaction was
stopped by the addition of 1 M H3 PO4 and ELISA plates
were measured at OD450 by using SPECTROstarNano microplate
reader (BMG Labtech).

fraction to final concentration of 50% (Wood, 1976) and stirred
for 1 h at RT. Sample was then subjected to centrifugation
10,000 × g for 30 min at RT. After decanting supernatant, pellet
was suspended in 500 µl PBS buffer. Sample was dialyzed ON
against PBS in a dialysis tube with pore size 3.5 (Roth).

Growth Assays
Growth kinetics were performed as previously described in M9chitin or M9-GlcNAc with following modifications (Schild et al.,
2007). Briefly, 1pglLVc 1rbmD or WT were grown in a M9-Glc
pre-culture ON and inoculated in M9-chitin or M9-GlcNAc to a
starting OD600 = 0.025. To determine the exact CFUs appropriate
dilutions were plated on LB plates at 0, 24, 48, and 72 h. Before
plating each culture was rigorously mixed by vortexing. The
cultures were incubated at 37◦ C with aeration and samples were
collected after 24, 48, and 72 h. Results are given as CFU/ml
normalized to a starting concentration of 107 CFU/ml at t = 0 h.

Statistical Analysis
Data were analyzed using the Mann–Whitney U test or a
Kruskal–Wallis test followed by post hoc Dunn’s multiple
comparisons. Differences were considered significant at
P-values of <0.05. For all statistical analyses, GraphPad Prism
version 6 was used.

Generation of Whole Cell Extracts
Whole cell extracts were generated by collecting the pellet of
20 ml culture by centrifugation 5 min at 5,000 × g. Pellet was
suspended in 1 ml of PBS buffer and transferred to a cryotube.
Glass beads (0.5 mm in diameter, Roth) were added to the
sample and lysed using the PowerLyserTM Bench Top BeadBased Homogenizer (MO BIO Laboratories, Inc.) 3 times 1 min,
with 1 min incubation steps on ice after each round of lysis.
Samples were centrifuged 2 min at 10,000 × g to remove cell
debris and unbroken cells. Supernatant was separated from glass
beads and used as WCE.

RESULTS
Reverse Glycoengineering Reveals That
PglLVc Glycosylates Multiple V. cholerae
Proteins
The activity of PglLVc has only been shown in a heterologous
E. coli system via simultaneous expression of PglLVc along
with a defined glycan and protein acceptors for O-linked
protein glycosylation from foreign bacteria (Gebhart et al.,
2012). Although this demonstrated functionality of PglLVc
with relaxed glycan specificity, O-linked protein glycosylation
has not been documented in V. cholerae. Hence, neither
the transferred glycan structure nor glycosylated proteins of
V. cholerae are known. Along this study we focused on the
latter and exploited the relaxed glycan specificity of PglLVc
along with a well-characterized glycan biosynthesis locus from
N. gonorrhoeae to identify a first set of glycosylated proteins
in V. cholerae. Therefore, we introduced a plasmid harboring
the core pglFBCD glycosylation locus from N. gonorrhoeae
into V. cholerae to express the lipid-linked monosaccharide
precursor Und-PP-diNAcBac. Proteins glycosylated with
diNAcBac monosaccharide could then be readily detected
using the specific monoclonal antibody npg1 (Aas et al., 2007;
Faridmoayer et al., 2007; Egge-Jacobsen et al., 2011; Anonsen
et al., 2015). Immunoblotting of WCE revealed a number of
distinct npg1-reactive proteins whose detection was dependent
on the presence of both PglLVc and the N. gonorrhoeae pgl
plasmid (Figure 1A). Moreover, these findings were independent
on the presence or absence of RbmD. This indicates that
PglLVc , in contrast to RbmD, can utilize the diNAcBac glycan
to modify a defined subset of V. cholerae proteins. Hence,
we focused on the identification of proteins glycosylated
via PglLVc .
To identify V. cholerae proteins bearing the diNAcBac
monosaccharide, immunoaffinity purification was employed as

CT ELISA
Cholera toxin production in culture supernatants or periplasmic
fractions was determined by the ganglioside GM1 ELISA (Pressler
et al., 2016). V. cholerae strains were grown ON in LB medium
supplemented with 5% glucose, which is beneficial for growth
of the 1epsC-N (Sikora et al., 2007). On the following day,
strains were shifted to AKI broth with 5% glucose, which
represents virulence gene inducing conditions. Strains were
grown at 37◦ C for 4 h anaerobically, followed by 4 h aerobic
growth with shaking at 180 rpm (Iwanaga et al., 1986). For
complementation strains, which have been grown and induced
with IPTG on 37◦ C, neither LB medium nor AKI broth
contained additional glucose to avoid interference with Ptac
promotor expression. Subsequently, cells were removed from CT
containing supernatants by centrifugation and supernatants were
stored at –20◦ C. Periplasmic fractions were obtained from the
cell pellet as described above (see section “Cell Fractionation”)
and adjusted to protein equivalents (Bradford). ELISA plates
(BRANDplates , 96-well, immunoGradeTM ) were coated with
10 µg/ml GM1 ganglioside (Calbiochem) in 60 mM Na2 CO3
ON at 37◦ C and washed four times with PBS pH 7.4 and
0.5% Tween (PBS-T). Free binding sites were blocked with
4 mg/ml BSA in PBS (BSA-PBS) for 1 h at RT. After washing
as described above, CT containing supernatants were diluted in
PBS and added to the plate. Additionally, purified CT in PBS
(Sigma-Aldrich) was inoculated in separate wells to generate a
standard curve. ELISA plates were incubated with supernatants
R
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FIGURE 1 | Expression of the diNAcBac glycan in V. cholerae results in multiple glycosylated proteins in a PglLVc -dependent manner. (A) Shown is a representative
immunoblot using the anti-diNAcBac antibody (npg1) to detect diNAcBac-glycosylated proteins and the corresponding Kang-stained SDS-gel of whole cell extracts
derived from 1pglLVc 1rbmD with or without in trans expression of respective O-OTases PglLVc or RbmD (+ = pMMBneo-pglLVc or pMMBneo-rbmD; – = pMMBneo)
as well as the diNAcBac glycan (+ = pACYCpglFBCD; – = pACYC184). Only the presence of PglLVc and diNAcBAc yielded in the detection of multiple bands.
(B) Shown is an immunoblot using the npg1-antibody to detect diNAcBac-glycosylated proteins and the corresponding Kang-stained SDS-gel of
immunopreciptated samples of 1pglLVc 1rbmD expressing the diNAcBac glycan (pACYCpglFBCD) in the presence (+ = pMMBneo-pglLVc ) or absence
(- = pMMBneo) of PglLVc . Immunoprecipitation was performed using npg1 immobilized onto Dynabeads coupled with protein G in combination with membrane and
periplasmic enriched protein samples from the respective strains. Selected protein bands, which appear to be enriched upon presence of PglLVc on the SDS-gel and
resulted in a decent signal on the immunoblot, were excised and subjected to MS. Identified proteins are indicated on the right with their respective position on the
gel, protein identities and accession numbers. (A,B) Lines to the left indicate the molecular masses of the protein standards in kDa.

isomerases (SurA-like and FkpA) and the chaperone/protease
DegP (Figure 1B).

previously described (Anonsen et al., 2012) using samples
enriched for membrane and periplasmic proteins from various
backgrounds as prey (Figure 1B). Immunoblotting using the
npg1 monoclonal antibody of immunoprecipitated samples
revealed a number of proteins specifically detected in the
presence of both PglLVc and the N. gonorrhoeae pgl plasmid.
Besides several bands with low intensity the immunoblot shows
two intense bands at approximately 50 and 25 kDa. The
50 kDa band is likely a cross-reacting band as it also detected
in absence of PglLVc . In contrast, the 25 kDa band only
appears in presence of PglLVc , but its exact nature remains
to be elucidated.
Robust signals obtained by immunoblot indicating
immunoaffinity purified proteins or complexes thereof, were
aligned to protein bands on a conventionally stained gel that
were subsequently excised and identified by mass spectrometric
(MS) techniques. The analyses revealed several proteins, such
as abundant outer membrane proteins OmpA and OmpU as
well as periplasmic chaperones, i.e., the peptidyl-prolyl cis-trans
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DegP Glycosylation Can Be
Reconstituted in an E. coli Background
In order to further validate the glycosylation status of the
proteins identified above, the ability of DegP as a representative
candidate to be glycosylated in a heterologous system was
examined. Plasmids individually expressing PglLVc , a C-terminal
His-tagged DegP and Und-PP-diNAcBac were introduced into
the glycosylation-deficient E. coli strain CLM24. Following a Histag purification, samples were subjected to immunoblot analyses
using penta-His or npg1 antibodies as well as conventional gel
staining (Figure 2A). Co-expression of PglLVc and Und-PPdiNAcBac was both necessary and sufficient to establish reactivity
of DegP with npg1, indicative of diNAcBac modification
(Figure 2A). In addition, a cross-reactive band (∼20 kDa)
was detected by the npg1 antibody upon expression of the
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FIGURE 2 | PglLVc glycosylates DegP with the diNAcBac glycan. (A) Ni-sepharose purified samples of E. coli CLM24 with varying expression of PglLVc
(pMMBneo-pglLVc ), the diNAcBac glycan (+ = pACYCpglFBCD; – = pACYC184) and/or His-tagged DegP (+ = pQE60-degP; – = pQE60), respectively, were
subjected for immunoblot analyses using the penta-His antibody or the npg1 antibody. A corresponding Kang-stained SDS-gel served as control. The arrow
highlights the location of the His-DegP band (approx. 46 kDa). Only in the presence of PglLVc , diNAcBac, and His-DegP a band of similar size can be detected with
the npg1 antibody, suggesting a diNAcBac-modification of His-DegP. Lines to the left indicate the molecular masses of the protein standards in kDa. (B,C)
Identification of GluC-derived glycopeptides from DegP. HCD MS/MS spectra of the [M+2H+]2+ precursor ions at m/z 720.917 and 613.803 of the
47 KVTPAVVSIAVE58 and 371 SLHQGLSGAE380 peptides respectively, modified with one glycan. Spectra show the reporter ions of diNAcBac at m/z 229.1, at m/z
211.1 and at m/z 169.1 in the low mass area. (D) Domain organization and location of DegP glycopeptides. Glycopeptides are numbered according to the DegP
sequence (generated by in-house sequencing). Red rectangles denote the location of the glycopeptide.

diNAcBac. It could be speculated that this band reflects the lipidlinked monosaccharide precursor Und-PP-diNAcBac (Und-PPdiNAcBac), but the exact origin remains to be elucidated.
Gel slices bearing His-tagged DegP were excised and
processed for MS analyses to detect glycan attachment sites.
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Utilizing LC-MS/MS employing higher-energy collision
dissociation in conjunction with in-gel digestion with trypsin
and GluC (HCD) (Anonsen et al., 2012) peptides covering
98% of DegP including two glycopeptides were identified
(Supplementary Figure S2A). Specifically, the MS/MS
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1pglLVc , 1rbmD, and 1pglLVc 1rbmD backgrounds compared
to WT (Figure 3A).
Restoration of PglLVc expression significantly lowered the
CT secretion compared to the 1pglLVc 1rbmD with an empty
vector control, while with restoration of RbmD expression, only
a mild reduction was observed (Figure 3B). In addition, the CT
levels in the periplasm were quantified for theses strains showing
an inverse pattern compared to secreted CT. Periplasmic CT
levels were significantly lower for 1pglLVc 1rbmD with an empty
vector compared to WT with empty vector. Moreover, PglLVc or
RbmD expression significantly increased periplasmic CT levels
compared to 1pglLVc 1rbmD with an empty vector. Again, equal
CT expression was observed in these strains with plasmids
indicated by comparable signal intensities in the respective WCE
(Supplementary Figure S3B). In comparison to the WT a
marked decrease of CT secretion for the T2SS-mutant 1epsC-N
and 1degP was observed (Figure 3A). Moreover, deletion of degP
in the 1pglLVc 1rbmD background (1pglLVc 1rbmD1degP) also
reduced CT secretion compared to 1pglLVc 1rbmD. Thus, degP is
epistatic to pglLVc and rbmD. In summary, CT is more efficiently
secreted in the absence of PglLVc and RbmD, while presence of
PglLVc and RbmD is associated with reduced translocation into
the supernatant resulting in accumulation of CT in the periplasm.
Next, we tried to pinpoint the potential origin of an
endogenous protein glycosylation by assuming that a defect in
endogenous glycan availability might phenocopy pglLVc - and
rbmD-mutants. In principle, V. cholerae encodes two major
glycan biosynthesis pathways, represented by the vps- (Vibrio
exopolysaccharide, VPS) and rfb- (O-antigen glycan) gene
clusters (Manning et al., 1995). To assess the potential influence
of these two pathways, CT secretion was quantified for strains
lacking either the rfb or vps genes. Similar to 1pglLVc , 1rbmD,
and 1pglLVc 1rbmD, mutants lacking the entire vps-I gene
cluster (1vps-I and 1pglLVc 1rbmD1vps-I) showed increased
CT levels in the supernatant compared to WT, whereas deletion
of rfb genes (1rfb) had no effect (Figure 3A). Deletion of
pglLVc and rbmD in addition to the vps-I gene cluster did not
further enhance the secreted CT levels. Moreover, 1vps-I and
1pglLVc 1rbmD showed a similar secretion efficacy of CT with
almost no detectable CT amounts in the periplasm and high levels
in the supernatant (Figure 3B). Notably, expression of PglLVc
and RbmD in 1vps-I (1vps-I p-pglLVc and 1vps-I p-rbmD) did
not restore detectable CT levels in the periplasm (Figure 3B).
These phenotypes provide a first hint that the vps cluster could
be involved in providing an endogenous glycan.

spectrum of the doubly charged precursor ion at m/z 720.917
(charge adjusted mass 1440.827 [M+H+]) corresponds to the
peptide 47 KVTPAVVSIAVE58 (theoretical monoisotopic mass
1212.720 [M+H+]) modified with a single diNAcBac moiety
(228.111 Da) (Figure 2B). Similarly, the MS/MS spectrum
of the doubly charged precursor ion at m/z 613.803 (charge
adjusted mass 1226.599 [M+H+]) corresponds to the peptide
371 SLHQGLSGAE380 (theoretical monoisotopic mass 998.490
[M+H+]) with a single diNAcBac modification (Figure 2C).
In addition to extensive y- and b-ions series that were detected
in both MS/MS spectra enabling the accurate amino acid
sequence determination for both peptides, the diNAcBac
specific reporter ions at m/z 229.118, at m/z 211.107 and at
m/z 169.096 (Anonsen et al., 2012) was detected in the low
mass area. The MS results therefore clearly establish both the
47 KVTPAVVSIAVE58 and the 371 SLHQGLSGAE380 peptides as
modified by a diNAcBac moiety at a single site (Figures 2B,C
and Supplementary Figures S2B,C).
Interestingly, both DegP glycopeptides are located within
defined domain structures. The 47 KVTPAVVSIAVE58
glycopeptide is localized within the protease domain whereas
the 371 SLHQGLSGAE380 glycopeptide is positioned in the
carbohydrate binding loop of the PDZ2 domain (Figure 2D),
which is suggested to be involved in substrate binding (Krojer
et al., 2002). Thus, if identical sites of glycan attachment occur in
V. cholerae, DegP activities might be altered.

PglLVc and RbmD Status Affect
Secretion of Cholera Toxin
Based on the confirmed O-glycosylation of DegP, the
identification of other periplasmic chaperones to be targets
for O-glycosylation in V. cholerae (Figure 1B) and a recent
report implying that DegP affects type II-dependent secretion
in V. cholerae (Altindis et al., 2014), we sought to examine
if PglLVc influences T2SS-associated phenotypes. Given the
structural similarities of RbmD to PglLVc and other established
oligosaccharyltransferases (Supplementary Figure S1) we also
examined the potential effects of RbmD, although the O-OTase
activity of RbmD remains to be confirmed. Thus, respective single
and double mutants (i.e., 1pglLVc , 1rbmD, and 1pglLVc 1rbmD)
as well as complementation strains for both gene products were
included in the following phenotypical analyses.
V. cholerae secretes several important T2SS effectors along its
lifecycle (Sikora, 2013). The most prominent example is probably
CT, which is predominantly responsible for the secretory diarrhea
during human colonization. To investigate whether secretion
of CT is affected in the context of the PglLVc , and RmbD
status, secretion levels of CT were compared for WT, 1degP,
1pglLVc , 1rbmD, 1pglLVc 1rbmD, and 1pglLVc 1rbmD1degP.
As a control, CT secretion was measured in a 1epsC-N
background that lacks essential parts of the T2SS machinery
and is therefore severely impaired for secretion. Of note, CT
expression remained equal in all strains tested as indicated
by comparable signal intensities in the WCE of respective
strains (Supplementary Figure S3A). Quantification of secreted
CT revealed significant higher levels in the supernatants of
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PglLVc and RbmD Affect Growth on
Chitin
In the aquatic lifestyle, V. cholerae secrets several proteins
of the chitin utilization program via the T2SS (Sikora et al.,
2011). As PglLVc and RbmD may generally affect secretion of
T2SS-dependent substrates including chitinases, mutants thereof
might exhibit altered growth on chitin. Therefore, we compared
growth dynamics of 1pglLVc , 1rbmD, and 1pglLVc 1rbmD
to the WT in minimal media supplemented with chitin or
its corresponding monomer GlcNAc as sole carbon sources,
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FIGURE 3 | O-OTases impact CT secretion. (A) The amount of secreted CT was determined in the culture supernatants by ELISA for V. cholerae WT, 1epsC-N,
1degP, 1pglLVc , 1rbmD, 1pglLVc 1rbmD, 1pglLVc 1rbmD1degP, 1vps-I, 1pglLVc 1rbmD1vps-I, and 1rfb. Strains were grown under virulence gene factor
expressing conditions (AKI conditions) to induce CT expression. (B) The amounts of secreted (open bars) and periplasmic (gray bars) CT for strains carrying empty
vector or complementation plasmids were determined in the culture supernatants and periplasmic fractions by ELISA. Periplasmic fractions were controlled for
cytoplasmic contamination and cell lysis via dot blot analyses detecting RpoA, the α-subunit of the RNA-Polymerase (for details see section “Dot Blot Analysis”).
A representative dot blot is shown in Supplementary Figure S4A, indicating equally low levels of cytoplasmic contamination for all periplasmic fractions. (A,B) The
data is given as median with interquartile range (n ≥ 8). Asterisks highlight significant differences between respective data sets (∗ P < 0.05 Kruskal–Wallis test
followed by post hoc Dunn’s multiple comparisons).

formation can already be observed at 24 h (Supplementary
Figure S5A), but phenotypes are more pronounced after 48 h
(Figure 5A). Here, the 1pglLVc mutant showed a slight, but
significant increase in static biofilm formation, while the 1rbmD
mutant and especially the 1pglLVc 1rbmD double mutant
exhibited pronounced increases in biofilm formation compared
to the WT (Figure 5A). In trans expression of both PglLVc
and RbmD in the double mutant significantly reduced biofilm
formation and allowed partial restoration of the WT phenotypes
at both time points (Figure 5B and Supplementary Figure S5B).
Three-dimensional biofilm morphology was microscopically
analyzed in a flow cell system using GFP-expressing backgrounds
(Seper et al., 2014). The 1pglLVc mutant and the 1pglLVc ,1rbmD
double mutant exhibited a significant increased attachment
capability, while the surface coverage of the 1rbmD mutant
was unaltered compared to the WT (Figures 6A,B). In mature
biofilms, distinct differences could be observed upon deletion
of pglLVc and rbmD (Figure 6C). Most pronounced phenotypes
in comparison to the WT were the increased biomass in case
of 1pglLVc biofilms and the enhanced maximum thickness and
higher roughness coefficient for 1rbmD biofilms (Figure 6D).
Biofilm formation of the double mutant 1pglLVc 1rbmD
combines characteristics of both single mutants with an increase
in attachment, biomass and maximum thickness (Figure 6D).
V. cholerae mutants exhibiting increased biofilm formation
can be frequently correlated with enhanced expression of vps
genes encoding proteins for the V. cholerae exopolysaccharide
(VPS) matrix synthesis and secretion (Yildiz and Schoolnik,
1999). To assess whether the enhanced biofilm formation
was related to enhanced vps expression here, chromosomal
transcriptional fusions of a promoterless phoA reporter gene
to vpsA representing one of the first genes in the vps-I locus,
were constructed in the WT and mutant backgrounds, as well

respectively (Figures 4A,B). All strains showed similar growth on
GlcNAc demonstrating equal uptake and metabolic usage of the
monosaccharide (Figure 4B). In contrast, the 1pglLVc , 1rbmD
and especially the 1pglLVc 1rbmD mutant showed enhanced
growth on chitin that gradually increased over the course of
72 h growth period compared to the WT (Figure 4A). Similar
to 1pglLVc 1rbmD mutant, the 1vps-I mutant also showed
enhanced growth on chitin, but similar growth on GlcNAc, if
compared to the WT (Figures 4A,B). In trans expression of
both PglLVc and RbmD in the double mutant did not affect
growth on GlcNAc, but significantly reduced growth on chitin
and allowed (partial) restoration of the WT phenotypes at 48 and
72 h (Figures 4C,D). In conclusion, single and double mutants of
pglLVc and rbmD have a fitness advantage compared to WT while
growing on chitin, consistent with the notion of a more efficient
secretion of chitinases as T2SS substrates.

PglLVc and RbmD Affect Biofilm
Formation
Both, pglLVc and rbmD, have been previously identified in a
screen for genes up-regulated during dynamic biofilm formation
(Seper et al., 2014). In that report, they were excluded from
subsequent characterization as they did not meet the stringent
criteria for bona fide in biofilm induced and were at time only
annotated with unknown function. Of note, rbmD is part of the
rbm-gene cluster (rugosity and biofilm structure modulators) that
harbors the biofilm matrix protein genes rbmA and rbmC (Fong
et al., 2006; Fong and Yildiz, 2007). Based on this, we analyzed the
pglLVc and rbmD mutants for alterations in biofilm formation.
First, we focused on static biofilm formation after 24 and 48 h,
representing two time points frequently used for biofilm analyses
in V. cholerae (Seper et al., 2011). In general, altered biofilm
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FIGURE 4 | Deletion of O-OTases affects chitin utilization. (A,B) Shown is growth (CFU/ml) at indicated time points of WT, 1pglLVc , 1rbmD, 1pglLVc 1rbmD, and
1vps-I in minimal media M9 supplemented with chitin (A) or supplemented with GlcNAc (B) as a sole carbon source. (C,D) Shown is growth (CFU/ml) at indicated
time points of WT with empty vector (WT p), 1pglLVc 1rbmD with empty vector (1pglLVc 1rbmD p), 1pglLVc 1rbmD p-pglLVc , and 1pglLVc 1rbmD p-rbmD in
minimal media M9 supplemented with chitin (C) or supplemented with GlcNAc (D) as a sole carbon source. (A–D) The data is given as median with interquartile
range (n ≥ 8). Asterisks highlight significant differences between respective data sets (∗ P < 0.05 Kruskal–Wallis test followed by post hoc Dunn’s multiple
comparisons).

of PhoA activity indicating similar transcription levels of vpsA in
these strains (Supplementary Figure S5C). Thus, the alterations
in biofilms and attachment cannot be simply explained by
elevated transcription of VPS genes.

RbmD Restricts RbmA Secretion in a
VPS Dependent Manner
As vps expression was unaltered in the 1pglLVc 1rbmD mutant,
we hypothesized that the alterations in biofilm amounts and
architecture could be due to differential secretion of the T2SS
substrates RbmA, RbmC or Bap1, which represent three major
adhesive protein components of the V. cholerae biofilm matrix
(Absalon et al., 2011; Berk et al., 2012). We therefore deleted
rbmA, rbmC and bap1 independently in the WT, 1pglLVc ,
1rbmD, and 1pglLVc 1rbmD backgrounds and tested biofilm
formation. Individual mutants 1rbmA, 1rbmC, and 1bap1
exhibit similar biofilm levels compared to the WT in the static
biofilm assay (Figure 7A), which is concordant with a previous
report as single deletion of each of the three matrix proteins does
not impact biofilm formation (Fong et al., 2006). The absence of
PglLVc and RbmD still resulted in increased biofilm formation
in the 1rbmC and 1bap1 backgrounds (Figure 7A). Similarly,
1pglLVc and 1rbmA1pglLVc showed equally enhanced biofilm
levels compared to the WT. Deletion of rbmA in the 1rbmD
or 1pglLVc 1rbmD background negated the RbmD-dependent
biofilm phenotypes and resulted in significant lower biofilm
amounts compared to the parental 1rbmD or 1pglLVc 1rbmD

FIGURE 5 | O-OTases impact static biofilm formation. The biofilm formation
capacity of the strains indicated on the x-axis was assayed under static
conditions by crystal violet staining and subsequent determination of the
OD595 (n ≥ 24). (A) Biofilms of WT, 1pglLVc , 1rbmD and 1pglLVc 1rbmD
were quantified after 48 h. (B) In trans expression of PglLVc or RbmD partially
restores biofilm to WT levels at 48 h. (A,B) The data is given as median with
interquartile range (n ≥ 24). Asterisks highlight significant differences between
the indicated data sets (∗ P < 0.05 Kruskal–Wallis test followed by post hoc
Dunn’s multiple comparisons).

as in the 1hapR mutant, which served as a positive control for
de-repressed vpsA expression (Seper et al., 2011). Thus, PhoA
activities reflect the transcription levels of vpsA in the respective
strains. O-OTase mutants and WT exhibited comparable levels
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FIGURE 6 | O-OTases alter attachment on abiotic surfaces and 3-dimensional biofilm architecture. (A) Shown are representative confocal microscopy images of
surface coverage after 2 h incubation time reflecting attachment properties. (B) The median surface coverage of GFP-expressing WT and deletion mutants after 2 h
incubation in flow cell chambers was determined by the COMSTAT software (n ≥ 6). (C) Shown are representative confocal laser scanning microscopy images of
GFP-expressing WT and deletion mutant biofilms as horizontal (xy) and vertical (xz and xy) projections. Biofilms were allowed to mature for 24 h in flow cell chambers
with constant 2% LB medium flow. The xy panels represent selected single optical sections through the three-dimensional data sets at the indicated z position
(z = 40, steps = 0.13 µm). (D) Biofilm parameters such as biomass, the maximum thickness and the roughness coefficient of WT and mutants were analyzed using
COMSTAT software (n ≥ 13). (A,C) Images were obtained with Leica SP5 confocal microscope. (B,D) Data is presented as median with interquartile range. Asterisks
highlight significant differences between respective data sets (∗ P < 0.05 Kruskal–Wallis test followed by post hoc Dunn’s multiple comparisons).

strains (Figure 7A). This phenotypic analysis thus revealed
synthetic genetic interactions between rbmA and rbmD.
To further investigate the relationships between RbmD and
RbmA, we examined RbmA trafficking using strains expressing
a His-tagged derivative allowing immunoblot analysis. In the
absence of PglLVc and RbmD, RbmA was relatively efficiently
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secreted into the supernatant with a reciprocal minority localized
in the periplasmic fraction. Remarkably, expression of solely
RbmD, but not PglLVc , effectively reversed RbmA localization
resulting in its relative accumulation in the periplasmic fraction
and reduced translocation into the supernatant (Figure 7B).
RbmD thus diminishes the secretion efficacy of RbmA, providing
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FIGURE 7 | O-OTases impact RbmA secretion. (A) Deletion of rbmA, but not rbmC or bap1, negates the increased biofilm formation in O-OTase mutants. The
biofilm formation capacity of the strains indicated on the x-axis were quantified after 48 h under static conditions by crystal violet staining and subsequent
determination of the OD595 (n ≥ 24). (B–D) Shown are representative immunoblots detecting His-RbmA in whole cell extracts (WCE), periplasmic fractions (PF), and
supernatants (SUP) of strain 1pglLVc 1rbmD1rbmA (B), 1pglLVc 1rbmD1rbmA1vps-I (C), or 1pglLVc 1rbmD1rbmA1rfb (D) expressing His-tagged RbmA in trans
(pQE60-rbmA) in the presence or absence of RbmD (pMMBneo-rbmD or pMMBneo), respectively. Equal amounts of proteins for WCE, PF or SUP were loaded
according to Bradford to allow direct comparison of the fractions. Semiquantitative densitometric evaluation of detected His-RbmA was performed with the Quantity
One software (Bio-Rad Laboratories) and is indicated below the immunoblots as arbitrary intensity units [mean AIU with standard deviation (n ≥ 3)] normalized to
WCE of the respective strain, which was always set to 1. Notably, TCA precipitation of PF and SUP was necessary to ensure stable detection. Similar efficiency of
protein precipitation for PF and SUP using TCA was controlled by spiking the samples with BSA prior to the precipitation and subsequent immunoblot analyses
detecting BSA in the precipitated samples. A representative immunoblot is shown in Supplementary Figure S6, indicating equal precipitation efficiency in all
samples. Moreover, PF obtained after TCA precipitation were controlled for differential cytoplasmic contamination and cell lysis via dot blot analyses detecting RpoA,
the α-subunit of the RNA-Polymerase (for details see section “Dot Blot Analysis”). A representative dot blot is shown in Supplementary Figure S4B, indicating
equally low levels of cytoplasmic contamination for all periplasmic fractions.

an example for differential secretion of a T2SS substrate
modulated by the status of RbmD.
Having revealed a RbmD-dependent periplasmic localization
of RbmA, we tried to pinpoint the origin of the glycan potentially
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transferred by RbmD. Based on the differential secretion pattern
of CT in presence or absence of the VPS, we focused on a
strain lacking the vps-I gene cluster. In the 1vps-I background
the RbmD-dependent periplasmic accumulation of His-tagged

15

December 2019 | Volume 10 | Article 2780

Vorkapic et al.

Vibrio cholerae O-Glycosylation System

generating smooth and rugose variants. The later shows elevated
VPS-production, increased biofilm formation and enhanced
resistance to several environmental stresses. While the work
herein is based on a smooth V. cholerae isolate, Fong and Yildiz
(2007) analyzed biofilm formation of a rbmD-mutant in a rugose
variant. In the rugose background deletion of rbmD resulted
in less compact biofilms and larger cell aggregates compared
to the parental rugose variant. However, direct comparison of
the results from our study and the work by Fong et al. is
difficult, due to the differential phenotypic background and
different V. cholerae isolates used. Based on the results presented
herein, we surmise that RbmD impacts on the same pathway as
that modulated by PglLVc in a non-redundant fashion. Besides
similarity PglLVc , RbmD is also related to WaaL-type O-antigen
ligases and members of the SEDS (shape, elongation, division and
sporulation) protein family members that serve as bacterial cell
wall polymerases (Meeske et al., 2016). The potential for RbmD
to have a role other than in protein glycosylation is intriguing
especially given its inability to use the UndPP-diNACBac donor
that can be used by virtually all O-OTases tested to date.
Another obvious point of interest relates to the nature of
the endogenous glycan used by PglLVc and potentially RbmD.
Computational analyses of the Sequence Similarity DataBase
revealed no obvious similarities of the entire gonococcal pgl
gene cluster in V. cholerae. However, similarity searches for
orthologs to the individual gonococcal pgl genes revealed several
hits in two gene clusters (VC0240–VC0263 and VC917–VC927)
encoding enzymes for the O-antigen biosynthesis and the Vibrio
exopolysacharide (VPS), respectively. Deletion of the vps-I gene
cluster (but not that for the O-antigen biosynthesis) phenocopied
pglLVc and rbmD mutants in the enhanced secretion of both
CT and RbmA, providing first evidence that the diverse sugars
present in the VPS [i.e., α-GulNAcAGly, α-Glcp, β-Glcp, α-Galp,
and α-D-GlcNAc (Yildiz et al., 2014)] or combinations thereof
may serve as at least one source for the transferred O-glycan
in V. cholerae. Notably, the VPS oligosaccharide is notoriously
recalcitrant to biochemical characterization as it is bound to a yet
unidentified component, which gives it high viscosity and which
would theoretically complicate its structural characterization by
MS as a post-translational protein modification.
Further insights into the mechanisms operating here will
undoubtedly require elucidation of the cognate glycoform
utilized by PglLVc and potentially by RbmD. Along this
line we tried to identify the glycan present in V. cholerae.
Briefly, His-tagged DegP was isolated in absence and presence
of PglLVc and/or RbmD and subjected to MS analysis, but
no defined modification could be identified. It should be
emphasized that detection and identification of a glycan with
unknown composition is not straightforward and requires
substantial expertise and instrumentation. A series of unfavorable
limitations decreased the likelihood of glycan identification: (i)
Overexpression of periplasmic His-tagged DegP reduced fitness
of V. cholerae. Thus, the yield of purified protein was relatively
low. (ii) The chemical composition of the natural glycan is
not only unknown, but might exhibit heterogeneity. Thus, the
glycosylated population may not represent a single peak in
the MS. (iii) O-glycosylation might render protein stability.

RbmA was negated and a robust translocation of His-tagged
RbmA was observed (Figure 7C). Concordant to the CT
data, RbmD-dependent periplasmic accumulation of His-tagged
RbmA was still observed in a 1rfb background (Figure 7D).
This suggests that the vps cluster can provide a glycan precursor
transferred by RbmD.

DISCUSSION
Here, we establish a clear association between O-linked protein
glycosylation mediated by the oligosaccharyltransferase PglLVc
and the efficacy of type II protein secretion-dependent processes
in the human pathogen V. cholerae. These findings define a first
connection between protein glycosylation and processes critical
to V. cholerae fitness in and outside of its host, such as differential
secretion of T2SS-dependent substrates including CT, chitinases
and the biofilm matrix protein RbmA. Moreover, we show
that mutants lacking RbmD, whose functions remain unknown
but shares structural features with PglLVc , exhibit phenotypic
perturbations analogous to those lacking PglLVc .
These findings raise the obvious question as to how O-linked
protein glycosylation status mediated by PglLVc might impact
on the translocation of type II protein secretion substrates
across the outer membrane. Perhaps the simplest explanation
would be that one or more of the glycoproteins targeted by
PglLVc influences type II protein secretion proficiency and that
the activity or functionality of that target protein is influenced
by its glycosylation status. Here, obvious candidates for such
glycoproteins would be DegP as well as other periplasmic
chaperones such as SurA and FkpA acting alone or in concert.
Nonetheless, we hypothesize that glycosylation of these and/or
other proteins might diminish their intrinsic functionality or
abundance. In this model, lack of glycosylation would thus
enhance their activity or levels to foster the terminal steps of
the T2SS. Confirmation of this model requires a more thorough
characterization of the V. cholerae glycoproteome and the effects
of O-linked protein glycosylation on glycoprotein abundance and
functionality. Notably, pglLV c is located upstream of the mshoperon encoding a surface pilus termed the mannose-sensitive
hemagglutinin (MSHA). Although not identified along our study,
it is tempting to speculate that O-glycosylation also targets
components of MSHA or affect their secretion as O-glycosylation
of pili components has been demonstrated for other bacteria
(Aas et al., 2007; Egge-Jacobsen et al., 2011). Notably, MSHA is
important for the first steps in biofilm formation by facilitating
adherence to abiotic and chitinous surfaces as well as for the
pharyngeal colonization of nematodes (Watnick et al., 1999;
Chiavelli et al., 2001; Meibom et al., 2004; List et al., 2018). Thus,
it cannot be excluded that the biofilm phenotypes of pglLVc and
rbmD mutants observed herein are at least partially associated to
differential MSHA functionality.
An intriguing aspect of this work relates to role of RbmD
whose mutation phenocopies that of the pglLVc null mutant. To
our knowledge, this is one of the first reports of these phenotypes
associated with the failure to express this protein in V. cholerae
WT. Notably, V. cholerae can undergo phenotypic variation
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(iv) Based on our results using the gonoccocal glycan only a
minor population of substrate is glycosylated, e.g., ∼1% in case
of DegP in presence of the diNAcBac glycan and PglLVc . It
should be noted, that such low modification rates could massively
affect overall DegP chaperone activity in the periplasm as DegP
monomers assemble from trimers and hexamers to multimeric
polyhedral cages with up to 24 subunits (Krojer et al., 2002;
Kim and Sauer, 2014). However, such modification rates further
reduce the chances for identification of the natural glycan. Based
on these limitations the identification of the cognate glycan seems
to be a challenging task for the future.
In summary, we herein reveal multiple gene interactions that
ultimately impact on the efficacy of the V. cholerae T2SS at the
level of translocation of substrates from the periplasm to the
extracellular milieu. T2SS modulation affects several stages of
the pathogens’ lifecycle as highlighted by the diverse phenotypes
reported herein. It is tempting to speculate that O-glycosylation
provides a post-translational mechanism allowing bacterial cells
to accumulate effector proteins, like RbmA, chitinases or CT
in the periplasm to be readily available for release when the
cells settle down on the new substratum for biofilm formation
or at the colonization site in the gastrointestinal tract. Thus,
O-glycosylation via PglLVc and possibly RbmD could represent
a fine-tuned feedback mechanism controlling release of T2SS
effectors by modulation of secretion efficacy.
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